Efficacy and safety of elagolix in endometriosis: Disease duration subgroup analysis

被引：0
|
作者：
Gupta, N. [1 ]
Palve, T. [2 ]
Kamilya, G. [3 ]
Srivastava, S. [4 ]
Malathi, P. [5 ]
Bohir, S. [6 ]
Patel, J. S. [7 ]
Dash, M. K. [8 ]
Saigal, S. [9 ]
Savalia, K. P. [10 ]
Gupta, T. [11 ]
Chaudhary, D. [12 ]
Manohar, R. [13 ]
Shah, P. [14 ]
Bhat, V. V. [15 ]
Shetty, A. [16 ]
Saha, S. [16 ]
Quadros, R. [16 ]
Patil, D. [16 ]
Patel, P. [16 ]
Ghadge, P. [16 ]
Mane, A. [16 ]
Mehta, S. [16 ]
机构：
[1] GSVM Med Coll, Kanpur, Uttar Pradesh, India
[2] Cama & Albless Hosp, Mumbai, Maharashtra, India
[3] IPGME&R & SSKM Hosp, Kolkata, India
[4] Om Surg Ctr & Matern Home, Varanasi, Uttar Pradesh, India
[5] Modern Govt Matern Hosp, Hyderabad, Telangana, India
[6] KKasturi Medicare Pvt Ltd, Thana, India
[7] Pagarav Hosp & ICU, Gandhinagar, India
[8] Sparsh Hosp & Crit Care Pvt Ltd, Bhubaneswar, India
[9] Brij Med Ctr Pvt Ltd, Kanpur, Uttar Pradesh, India
[10] Priyadarshani Nursing Home, Virar E, India
[11] Udyan Hlth Care Pvt Ltd, Lucknow, Uttar Pradesh, India
[12] SMS Hosp, Jaipur, Rajasthan, India
[13] Mandya Inst Med Sci, Mandya, India
[14] SVP Hosp, Ahmadabad, Gujarat, India
[15] Radhakrishna Multispecial Hosp & IVF Ctr, Bangalore, Karnataka, India
[16] Sun Pharma Labs Ltd, Mumbai, Maharashtra, India
来源：
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY | 2024年 / 131卷
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
eP-075
引用
收藏
页码：77 / 78
页数：2
相关论文
共 50 条
  • [1] Efficacy and safety of Elagolix in endometriosis: Baseline NRS score subgroup analysis
    Gupta, N.
    Palve, T.
    Kamilya, G.
    Srivastava, S.
    Ponnuru, M.
    Bohir, S.
    Patel, J.
    Dash, M.
    Saigal, S.
    Savalia, K.
    Gupta, T.
    Chaudhary, D.
    Rangaswamy, M.
    Shah, P.
    Bhat, V. V.
    Shetty, A.
    Saha, S.
    Quadros, R.
    Patil, D.
    Patel, P.
    Ghadge, P.
    Mane, A.
    Mehta, S.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2024, 131 : 75 - 76
  • [2] Efficacy of elagolix in the treatment of endometriosis
    Perricos, Alexandra
    Wenzl, Rene
    EXPERT OPINION ON PHARMACOTHERAPY, 2017, 18 (13) : 1391 - 1397
  • [3] Long-Term Safety and Efficacy of Elagolix Treatment in Women With Endometriosis-Associated Pain
    Surrey, Eric
    Taylor, Hugh S.
    Duan, W. Rachel
    Peloso, Paul
    Schwefel, Brittany
    Chwalisz, Kristof
    OBSTETRICS AND GYNECOLOGY, 2018, 131 : 4S - 4S
  • [4] EFFICACY AND SAFETY OF ELAGOLIX IN A SUBGROUP OF WOMEN WITH UTERINE FIBROIDS AND ADENOMYOSIS: RESULTS FROM A PHASE 2 TRIAL
    Taylor, H. S.
    Bedaiwy, M. A.
    Lukes, A. S.
    Chwalisz, K.
    Owens, C.
    Bradley, L.
    FERTILITY AND STERILITY, 2018, 110 (04) : E61 - E61
  • [5] The short- and mid-term efficacy and safety of elagolix in the management of pain associated with endometriosis: A systematic review and meta-analysis
    Zhang, Yue
    Wei, Wei
    Chang, En
    Leng, Yan-en
    Hou, Yi
    Wei, Xi
    Yue, Xin
    Zhong, Li
    Liu, Jin-feng
    JOURNAL OF GYNECOLOGY OBSTETRICS AND HUMAN REPRODUCTION, 2024, 53 (09)
  • [6] Elagolix Exposure-Efficacy Analysis
    不详
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 108 (04) : 691 - 691
  • [7] Safety and efficacy of pharmacotherapies for pelvic inflammatory disease and endometriosis
    Ferrero, Simone
    Leone Roberti Maggiore, Umberto
    Paudice, Michele
    Vellone, Valerio Gaetano
    Perrone, Umberto
    Barra, Fabio
    EXPERT OPINION ON DRUG SAFETY, 2025, 24 (03) : 273 - 286
  • [8] Adalimumab efficacy and safety by disease duration: analysis of pooled studies of Crohn's disease
    Panaccione, R.
    Rutgeerts, P.
    Sandborn, W.
    Schreiber, S.
    Colombel, J. -F.
    Berg, S.
    Maa, J. -F.
    Petersson, J.
    Robinson, A. M.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S271 - S271
  • [9] ADALIMUMAB EFFICACY AND SAFETY BY DISEASE DURATION: ANALYSIS OF POOLED STUDIES OF CROHN'S DISEASE
    Panaccione, Remo
    Rutgeerts, Paul
    Sandborn, William J.
    Schreiber, Stefan
    Colombel, Jean Frederic
    Berg, Sofie
    Maa, Jen-Fue
    Petersson, Joel H.
    Robinson, Anne M.
    GASTROENTEROLOGY, 2017, 152 (05) : S744 - S744
  • [10] Efficacy and safety of Elagolix in endometriosis: Phase-III randomized double-blind active-controlled trial
    Gupta, N.
    Palve, T.
    Kamilya, G.
    Srivastava, S.
    Malathi, P.
    Bohir, S.
    Patel, J. S.
    Dash, M. K.
    Saigal, S.
    Savalia, K. P.
    Gupta, T.
    Chaudhary, D.
    Manohar, R.
    Shah, P.
    Bhat, V. V.
    Shetty, A.
    Saha, S.
    Quadros, R.
    Patil, D.
    Patel, P.
    Ghadge, P.
    Mane, A.
    Mehta, S.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2024, 131 : 3 - 3
12345